首页> 外国专利> Preparing 6,6-dimethyl-azabicyclo-methyl carboxylate, comprises e.g. substituting hydroxy-dimethyl-hexane-dimethyl-propyl ester by hydroxyl compound and cyaniding obtained pyrrolidine compound to give dimethylpropyl-azabicyclo-carboxylate

Preparing 6,6-dimethyl-azabicyclo-methyl carboxylate, comprises e.g. substituting hydroxy-dimethyl-hexane-dimethyl-propyl ester by hydroxyl compound and cyaniding obtained pyrrolidine compound to give dimethylpropyl-azabicyclo-carboxylate

机译:制备6,6-二甲基-氮杂双环-甲基羧酸盐包括,例如。用羟基化合物取代羟基-二甲基-己烷-二甲基-丙酯并氰化得到吡咯烷化合物,得到二甲基丙基-氮杂双环羧酸酯

摘要

Preparing (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-methyl carboxylate (A), comprises (a) substituting (1R,5S)-2-hydroxy-6,6-dimethyl-bicyclo[3.1.0]hexane-3-carboxylic acid 1,1-dimethyl-propyl ester by hydroxyl compound to give pyrrolidine compound (I), (b) cyaniding (I) to give 1,1-dimethylpropyl (1R,2S,5S)-2-cyano-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-3-carboxylate, and (c) deprotecting the 1,1-dimethylpropyl (1R,2S,5S)-2-cyano-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-3-carboxylate to give (A). Preparing (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-methyl carboxylate (A), comprises (a) substituting (1R,5S)-2-hydroxy-6,6-dimethyl-bicyclo[3.1.0]hexane-3-carboxylic acid 1,1-dimethyl-propyl ester by hydroxyl compound of formula (Alk-OH) to give pyrrolidine compound of formula (I), (b) cyaniding (I) to give 1,1-dimethylpropyl (1R,2S,5S)-2-cyano-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-3-carboxylate, and (c) alcoholysis and deprotecting the 1,1-dimethylpropyl (1R,2S,5S)-2-cyano-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-3-carboxylate to give (A).Alk = 1-6C alkyl. Independent claims are included for: (1) (1R,5S)-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester compound of formula (II); and (2) the preparation of boceprevir, comprising (A). Either R1, R2 : H; and R2 : -OH, O-Alk or -CN; or R1R2 : (C=O). [Image] [Image] ACTIVITY : Antiinflammatory; Hepatotropic; Virucide. MECHANISM OF ACTION : None given.
机译:制备(1R,2S,5S)-6,6-二甲基-3-氮杂双环[3.1.0]己烷-2-甲基羧酸酯(A),包括(a)取代(1R,5S)-2-羟基-6,通过羟基化合物将6-二甲基-双环[3.1.0]己烷-3-羧酸1,1-二甲基-丙酯生成吡咯烷化合物(I),将(b)氰化(I)生成1,1-二甲基丙基( 1R,2S,5S)-2-氰基-6,6-二甲基-3-氮杂双环[3.1.0]己烷-3-羧酸酯,和(c)脱保护1,1-二甲基丙基(1R,2S,5S)- 2-氰基-6,6-二甲基-3-氮杂双环[3.1.0]己烷-3-羧酸酯得到(A)。制备(1R,2S,5S)-6,6-二甲基-3-氮杂双环[3.1.0]己烷-2-甲基羧酸酯(A),包括(a)取代(1R,5S)-2-羟基-6,由式(Alk-OH)的羟基化合物合成6-二甲基-双环[3.1.0]己烷-3-羧酸1,1-二甲基-丙酯,得到式(I)的吡咯烷化合物,(b)氰化(I ),得到1,1-二甲基丙基(1R,2S,5S)-2-氰基-6,6-二甲基-3-氮杂双环[3.1.0]己烷-3-羧酸酯,和(c)醇解并保护1, 1-二甲基丙基(1R,2S,5S)-2-氰基-6,6-二甲基-3-氮杂双环[3.1.0]己烷-3-羧酸酯得到(A)。烷基= 1-6C烷基。包括以下独立权利要求:(1)式(II)的(1R,5S)-6,6-二甲基-3-氮杂-双氮杂[3.1.0]己烷-3-羧酸叔丁酯化合物; (2)博西普韦的制剂,其包含(A)。 R1,R2:H;和R 2:-OH,O-Alk或-CN;或R1R2:(C = O)。 [图像] [图像]活动:抗炎;肝杀病毒剂。作用机理:未给出。

著录项

  • 公开/公告号FR2972453A1

    专利类型

  • 公开/公告日2012-09-14

    原文格式PDF

  • 申请/专利权人 MINAKEM;

    申请/专利号FR20110051928

  • 发明设计人 BERRANGER THIERRY;DEMONCHAUX PATRICE;

    申请日2011-03-09

  • 分类号C07D209/52;

  • 国家 FR

  • 入库时间 2022-08-21 17:04:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号